人工智能干预临床试验报告指南:CONSORT-AI扩展版
CONSORT-AI是评估含人工智能(AI)成分干预的临床试验报告新指南,与SPIRIT-AI并行制定。通过文献回顾、专家咨询产生29个候选条目,经103名利益相关者两阶段Delphi调查、31名利益相关者两天共识会议及34名参与者清单试点后形成,包含14个新增条目,建议在CONSORT 2010核心条目基础上常规报告。
要点
- CONSORT-AI包含14个新增条目,应与CONSORT 2010核心条目一起常规报告。
- 需清晰描述AI干预、使用说明与技能要求、整合场景及输入输出处理。
- 应报告人机交互情况并提供错误案例分析。
核心结论
- CONSORT-AI有助于促进AI干预临床试验报告的透明性和完整性,帮助理解、解读和批判性评估试验设计质量及报告结局的偏倚风险。
研究设计与样本
- 通过分阶段共识过程制定,包括文献回顾和专家咨询产生29个候选条目。
- 由国际多利益相关者组进行两阶段Delphi调查(103名利益相关者),在两天共识会议(31名利益相关者)上达成一致,并通过清单试点(34名参与者)完善。
主要发现
- CONSORT-AI扩展包含14个新增条目,这些条目被认为对AI干预足够重要,应在核心CONSORT 2010条目之外常规报告。
关键数值与推荐
- CONSORT-AI建议研究者清晰描述AI干预,包括使用所需的说明和技能、AI干预整合的场景、AI干预输入和输出的处理、人机交互,并提供错误案例分析。
临床怎么用
- 研究者在报告AI干预临床试验时应遵循CONSORT-AI,在CONSORT 2010核心条目基础上报告14个新增条目。
- 可帮助编辑、同行评审者和读者理解、解读和批判性评估AI干预临床试验设计质量及报告结局的偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The CONSORT 2010 (Consolidated Standards of Reporting Trials) statement provides minimum guidelines for reporting randomised trials. Its widespread use has been instrumental in ensuring transparency when evaluating new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes.The CONSORT-AI extension is a new reporting guideline for clinical trials evaluating interventions with an AI component. It was developed in parallel with its companion statement for clinical trial protocols: SPIRIT-AI. Both guidelines were developed through a staged consensus process, involving a literature review and expert consultation to generate 29 candidate items, which were assessed by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed on in a two-day consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants).The CONSORT-AI extension includes 14 new items, which were considered sufficiently important for AI interventions, that they should be routinely reported in addition to the core CONSORT 2010 items. CONSORT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention is integrated, the handling of inputs and outputs of the AI intervention, the human-AI interaction and providing analysis of error cases.CONSORT-AI will help promote transparency and completeness in reporting clinical trials for AI interventions. It will assist editors and peer-reviewers, as well as the general readership, to understand, interpret and critically appraise the quality of clinical trial design and risk of bias in the reported outcomes.
引用
- Liu X, Rivera SC, Moher D, et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension. BMJ. 2020. PMID: 32909959. doi:10.1136/bmj.m3164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。